Status
Conditions
Treatments
About
The aim of this clinical study to evaluate the effect of temporomandibular joint dysfunction accompanying patients with chronic migraine on pain, quality of life, sleep and functionality.
Full description
Patients who applied to Istanbul University - Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Neurology, headache outpatient clinic and were diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3), after the patient's history and physical examination, will be included in the study.
Date of birth, gender, education level, body mass index, occupation, marital status, socioeconomic status, age of onset of migraine complaints, descriptive information about migraine attacks (type (with or without aura), duration of attacks, mean number of days with pain) , pain intensity, accompanying) will be questioned.
In addition, patients with complaints and findings such as pain in the temporomandibular joint area and chewing muscles, limitation in mouth opening, noise from the joint during mouth opening and/or non-harmonic jaw movements will be evaluated by Alper Mengi in terms of temporomandibular joint dysfunction.
A total of 62 patients are planned to be included in the study. In the study, 2 groups will be formed, the first group will consist of chronic migraine patients, the second group will consist of patients with chronic migraine as well as temporomandibular joint dysfunction.
All patients will be evaluated for allodynia, quality of life, headache-related disability, and sleep quality. Relevant forms will be filled by patients.
Patients who are thought to have temporomandibular joint dysfunction will be evaluated by Alper Mengi for dysfunction.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For patients with chronic migraine:
For patients with temporomandibular dysfunction :
Exclusion criteria
For patients with chronic migraine:
In addition to the exclusion criteria above in patients with a diagnosis of temporomandibular joint dysfunction:
Primary purpose
Allocation
Interventional model
Masking
62 participants in 2 patient groups
Loading...
Central trial contact
Alper Mengi, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal